Carboxymethyl benzylamide dextran blocks angiogenesis of MDA-MB435 breast carcinoma xenografted in fat pad and its lung metastases in nude mice

Cancer Research

Volumn 59, Issue 3, 1999, Pages 507-510

  Bagheri Yarmand, Rozita ^a   Kourbali, Yamina ^a   Rath, Ana Maria ^a   Vassy, Roger ^a   Martin, Antoine ^b   Jozefonvicz, Jacqueline ^a   Soria, Claudine ^c   Lu, He ^c   Crépin, Michel ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b Service d'Anatomie Pathologie   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYMETHYL BENZYLAMIDE DEXTRAN; DEXTRAN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG METASTASIS; METASTASIS INHIBITION; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ADIPOSE TISSUE; ANIMALS; ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; COLLAGEN; DEXTRANS; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; LAMININ; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PROTEOGLYCANS; RECEPTORS, ESTROGEN; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0033083905     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-31, 1995.
2. Folkman, J., and Shing, Y. Angiogenesis. J. Biol. Chem., 267: 10931-10934, 1992.
3. Weidner, N., Semple, J. P. Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
4. Harris, A. L. Antiangiogenesis for cancer therapy. Lancet, 349 (Suppl.2): 13-15, 1997.
5. Bagheri-Yarmand, R., Bittoun, P., Champion, J., Letouneur, D., Jozefonvicz, J., Fermadjian, S., and Crépin, M. Carboxymethyl benzylamide dextrans inhibit breast cell growth. In Vitro Cell. Dev. Biol., 30A: 822-824, 1994.
6. Bagheri-Yarmand, R., Liu, J. F., Ledoux, D., Morère, J. F., and Crépin, M. Inhibition of human breast epithelial HBL100 cell proliferation by a dextran derivative (CMDB7): interference with the FGF-2 autocrine loop. Biochem. Biophys. Res. Commun., 239: 424-428, 1997.
7. Bagheri-Yarmand, R., Kourbali, Y., Mabilat, C., Morère, J. F., Martin, A., Lu, H., Soria, C., Jozefonvicz, J., and Crépin, M. The suppression of fibroblast growth factor 2/fibroblast growth factor 4-dependent tumour angiogenesis and growth by the anti-growth factor activity of dextran derivative (CMDB7). Br. J. Cancer, 78: 111-118, 1998.
8. Bagheri-Yarmand, R., Kourbali, Y., Morère, J. F., Jozefonvicz, J., and Crépin, M. Inhibition of MCF-7ras tumor growth by carboxymethyl benzylamide dextran: blockage of the paracrine effect and receptor binding of transforming growth factor β1 and platelet-derived growth factor-BB. Cell Growth Differ., 9: 497-504, 1998.
9. Price, J. E., Polzos, A., Zhang, R. D., and Daniels, L. M. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res., 50: 717-721, 1990.
10. Chaubet, F., Champion, J., Maîga, R., Maurey, S., and Jozefonvicz, J. Synthesis and structure-anticoagulant property relationships of functionalized dextrans: CMDBS. Carbohydr. Polym., 28: 145-152, 1995.
11. Cailleau, R., Young, R., Olive, M., and Reeves, W. J. Breast tumor cell lines from pleural effusions. J. Natl. Cancer Inst., 53: 661-674, 1974.
12. Kibbey, M. C., Grant, D. S., and Kleinman, H. K. Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo matrigel model. J. Natl. Cancer Inst., 84: 1633-1638, 1992.
13. Alroy, J., Goyal, V., and Skutelsky, E. Lectin histochemistry of mammalian endothelium. Histochemistry, 86: 603-607, 1987.
14. Weidner, N., Folkman, J., Pozza, F., Bevilaccqua, P., Allred, E. N., Moore, D. H, Meli, S., and Gasparini, G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst., 84: 1875-1887, 1992.
15. Gasparini, G., and Harris, A. L. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J. Clin. Oncol., 13: 765-782, 1995.
16. Tanigawa, N., Amaya, H., Matsumura, M., Shimomatsuya, T., Horiuchi, T., Muraoka, R., and Iki, M. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res., 56: 2671-2676, 1996.
17. Czubako, F., Schulte, A. M., Berchem, G. J., and Wellstein, A. Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin. Proc. Natl. Acad. Sci. USA, 93: 14753-14758, 1996.
18. Nagy, J. A., Brown, L. F., Senger, D. R., Lanir, N., Van de Water, L., Dvorak, A. M., and Dvorak, H. F. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim. Biophys. Acta, 948: 305-326, 1989.
19. Folkman, J., Langer, R., Linhardt, R. J., Haudenschild, C., and Taylor, S. Angiogenesis inhibition anf tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science (Washington DC), 221: 719-725, 1983.
20. Klauber, N., Parangi, S., Flynn, E., Hamel, E., and D'Amato, R. J. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res., 57: 81-86, 1997.
21. Boehm, T., Folkman, J., Browder, T., and O'Reilly, M. S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature (Lond.), 390: 404-407, 1997.